parthenolide has been researched along with Kidney Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coimbra, TM; Costa, RS; Francescato, HD; Scavone, C | 1 |
1 other study(ies) available for parthenolide and Kidney Diseases
Article | Year |
---|---|
Parthenolide reduces cisplatin-induced renal damage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Cell Nucleus; Cisplatin; Electrophoretic Mobility Shift Assay; Glomerular Filtration Rate; Immunohistochemistry; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Kidney Diseases; Kidney Function Tests; Kidney Medulla; Kidney Tubules; Lipid Peroxidation; Lipid Peroxides; Male; NF-kappa B; Nuclear Proteins; Oxidative Stress; Rats; Rats, Wistar; Sesquiterpenes; Superoxides | 2007 |